CH3 DOMAIN EPITOPE TAGS
This invention relates to the incorporation of one, or more, heterologous antibody epitopes into the AB, EF, or CD structural loops of the constant heavy domain 3 (''CH3 domain'') of an engineered antibody or Fc-linked therapeutic agent. The heterologous epitopes serve as "e...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to the incorporation of one, or more, heterologous antibody epitopes into the AB, EF, or CD structural loops of the constant heavy domain 3 (''CH3 domain'') of an engineered antibody or Fc-linked therapeutic agent. The heterologous epitopes serve as "epitope tags" that are specifically detectable by epitope tag-specific detector antibodies, irrespective of the tagged agent'starget specificity. Therefore, the epitope tags are useful for the rapid detection of any tagged antibody or Fc- linked agent in biological samples, including samples, which also contain endogenous antibodies.
本发明涉及将一种或多种异源抗体表位掺入工程化抗体或Fc连接的治疗剂的恒定重链结构域3("CH3结构域")的AB、EF或CD结构环中。异源表位充当"表位标签",其可以由表位标签特异性检测抗体特异性检测,而与标记药剂的靶标特异性无关。因此,表位标签可用于快速检测生物样品(包括还含有内源性抗体的样品)中任何标记的抗体或Fc连接药剂。 |
---|